Faculty of Medicine, School of Biomedical Sciences, The University of Queensland, Brisbane, QLD, Australia.
Front Immunol. 2020 May 8;11:704. doi: 10.3389/fimmu.2020.00704. eCollection 2020.
Individuals with traumatic spinal cord injury (SCI) suffer from numerous peripheral complications in addition to the long-term paralysis that results from disrupted neural signaling pathways. Those living with SCI have consistently reported gastrointestinal dysfunction as a significant issue for overall quality of life, but most research has focused bowel management rather than how altered or impaired gut function impacts on the overall health and well-being of the affected individual. The gut-brain axis has now been quite extensively investigated in other neurological conditions but the gastrointestinal compartment, and more specifically the gut microbiota, have only recently garnered attention in the context of SCI because of their vast immunomodulatory capacity and putative links to infection susceptibility. Most studies to date investigating the gut microbiota following SCI have employed 16S rRNA genomic sequencing to identify bacterial taxa that may be pertinent to neurological outcome and common sequalae associated with SCI. This review provides a concise overview of the relevant data that has been generated to date, discussing current understanding of how the microbial content of the gut after SCI appears linked to both functional and immunological outcomes, whilst also emphasizing the highly complex nature of microbiome research and the need for careful evaluation of correlative findings. How the gut microbiota may be involved in the increased infection susceptibility that is often observed in this condition is also discussed, as are the challenges ahead to strategically probe the functional significance of changes in the gut microbiota following SCI in order to take advantage of these therapeutically.
创伤性脊髓损伤 (SCI) 患者除了由于神经信号通路中断导致的长期瘫痪外,还会遭受许多外周并发症。患有 SCI 的患者一致报告胃肠道功能障碍是整体生活质量的一个重大问题,但大多数研究都集中在肠道管理上,而不是肠道功能的改变或受损如何影响受影响个体的整体健康和幸福。目前,其他神经疾病中已经广泛研究了肠脑轴,但胃肠道(更具体地说是肠道微生物群)在 SCI 背景下最近才引起关注,因为它们具有广泛的免疫调节能力,并可能与感染易感性有关。迄今为止,大多数研究 SCI 后肠道微生物组的研究都采用 16S rRNA 基因组测序来鉴定可能与神经功能结果和与 SCI 相关的常见后遗症有关的细菌分类群。这篇综述简要概述了迄今为止生成的相关数据,讨论了目前对 SCI 后肠道微生物含量如何与功能和免疫结果相关联的理解,同时还强调了微生物组研究的高度复杂性,以及需要仔细评估相关性发现。还讨论了肠道微生物组如何参与这种情况下经常观察到的感染易感性增加,以及未来的挑战是如何战略性地探测 SCI 后肠道微生物组变化的功能意义,以利用这些治疗方法。